 Good afternoon. Today we have the privilege of speaking with Dr. Raul Kouchois about something that's first front of everybody's mind right now, which is COVID-19 and how we're actually living with it presently and how we're all going to go back to work. And of course you have a solution, don't you? Oh yes, absolutely. So with COVID-19 now, what we are realizing is it's really becoming a part of our daily lifestyle. I mean, we are in this lockdown, but the reality is you cannot be shutting down economies forever. And that is precisely where our technology comes into play. So what we are saying is that yes, you can open facilities, you can open workplaces, but it's about running in technologies that can create those safety bubbles in those places. And that is where our infectious disease symptoms-tweeting solution or our safe entry system comes into play. Because the technology is about identifying a host of symptoms that associate with COVID-19 and this goes beyond just fever. So it acts more like a triage. So as people are passing through, they're being screened for a host of symptoms. And if someone is identified to be exhibiting a symptom within a fraction of a second, you have the output in the form of a red light. And then in the facility, I mean, the employer or let's say if it's an arena, they can have the right protocols in terms of what needs to be done next once somebody has been flagged as exhibiting the symptoms. Okay. So if I understand this properly, of course, this is AI-driven technology. It's a remote censoring system called the Safe Entry Station. Is that correct? That's right. Now I understand there's a lot of companies out there that have all kinds of interesting things that you can walk through, sensors, etc. I've seen yours. They look fantastic. In fact, we're going to show a couple of slides in this interview about what you have. But yours is quite sensitive and provide some additional competitive advantages. Can you talk to us about this? Yes. First and foremost, it's looking at several symptoms that associate with infectious diseases. So it's not just another fever scanner. And at the same time, I mean, there is a deep learning algorithm which learns in the background. And what it means is as more and more people pass through the system, the system keeps on getting smarter. And along with that, with our technology, it's not just about having a temporary solution, which is only going to be here as long as COVID-19 is there. It's about having more of a permanent solution that you put perhaps in a workplace setting because you got to remember, every year we are hit by influenza as well. And that does carry a huge toll when it comes to workplaces. And of course, I think I would like to just hit on the business. You have a couple of major distributors in place already. And if I understand you have a Fortune 50 company from India as well that you have a deal with, is that correct? That's right. And we have already deployed our technology with India Oil. I mean, again, one of the largest companies on the global level. Last year, their revenues were over $85 billion. And again, the key is, they were not looking for a temporary solution. They were looking more for a permanent solution that can increase or that can create a safer work environment. And that is where our technology came in. And at the same time, we have several other deployments that are in the planning stages which have not been announced yet. Well, I'll tell you, we're really looking forward to your updates. And if you could just give us some of the highlights from your corporate update that you just put out, having to do specifically with the safe entry stations, where we're all listening. Oh, for sure. So when it comes to our safe entry stations, I mean, of course, Juice Brooks is one of our partners here in North America. And for people who don't know what Juice Brooks or who they are, they work with some of the largest companies in North America for fabrication. So they are fabricating our safe entry stations. At the same time, they have brought on a very experienced team of sales staff. And those sales staff, I mean, they're really targeting some specific areas where we feel we can make a huge dent in terms of getting that business and targeting some strategic areas. Along with that, we have also brought on a consultant to help us navigate the public sector in Canada because that tends to be quite a different market altogether. Along with that, we have also signed a letter of intent with one of the largest and most prominent management consulting firms based out of North America with low operations. And their interest lies not just in our symptom screening technology, but also in our cannabis and alcohol impairment technology. And as we speak, we are working on a definitive sales agreement with them, which is something, as you can imagine, that can be quite big for predict medics. Along with that, I mean, in India, we have partnered with Paris Defense. They are one of the largest defense manufacturers and contractors in India. They are an approved government of India vendor, and they're keen on bringing or taking our technology to the government sector, not just in India, but all over Asia and the Middle East. So I mean, just from the safe entry perspective or infectious disease screening technology, there has been a lot which has been going on, and there is a lot which is happening as we speak. And again, one of the things, as they say, is that the stock price is not always reflective of the company or the underlying business. We are here to build long-term value for shareholders. We are here to build a true, sustainable, and a large technology company which will grow to become a business leader when it comes to workplace health and safety. And that is the mandate of predict medics. Well, as always, Dr. Kushwa, thank you so much for joining us today. We really appreciate the update. Thank you, Tracy.